The Omega-3 Index is Inversely Associated with the Neutrophil-Lymphocyte Ratio in Adults

Michael I. McBurney, Nathan L. Tintle, William S. Harris
doi: https://doi.org/10.1101/2021.10.22.21264656

Summary

The neutrophil-lymphocyte ratio (NLR) is a biomarker of systemic inflammation and measures innate-adaptive immune system balance. The omega-3-index (O3I) measures the amount of EPA+DHA in blood. Both a low O3I and an elevated NLR are associated with increased risk for chronic disease and mortality, including cardiovascular diseases and cancer. Hypothesizing that low O3I may partly contribute to systemic chronic inflammation, we asked if a relationship existed between O3I and NLR in healthy adults (≥18y, n=28,871, 51% female) without inflammation [C-reactive protein (CRP) <3mg/mL)] who underwent a routine clinical assessment. NLR was inversely associated with O3I before (p<0.0001) and after adjusting for age, sex, BMI, and CRP (p<0.0001). Pearson correlations of other variables with NLR were r=0.06 (CRP), r=0.14 (age), and r=0.01(BMI). In this healthy population, an O3I <6.6% was associated with increasing NLR whereas NLR remained relatively constant (low) when O3I >6.6%, suggestive of a quiescent, balanced immune system.

1. Introduction

Cells from both the innate and adaptive immune system circulate in blood. Cells of the former (i.e., neutrophils, phagocytes, dendritic cells, macrophages, eosinophils, basophils, mast cells, and natural killer cells) work together to neutralize pathogens, in part by releasing pro-inflammatory mediators that modulate the latter. Neutrophils are the most abundant leukocytes in circulation. They migrate to sites of tissue injury or damage and are responsible for a non-specific inflammatory response. The adaptive system (acquired immunity) responds to specific pathogens and cytokines by producing antibodies and maintains immunological memory via lymphocytes, i.e., T and B cells. The hallmark of the adaptive immune system is clonal expansion of lymphocytes. Inflammation is generally self-limiting, with its resolution being an active rather than passive process [1]. Chronic or unresolved inflammation can damage host tissues and increase risk for the development of a range of non-communicable diseases, e.g. cardiovascular, cancer, chronic respiratory diseases, diabetes, and autoimmune disorders, e.g. rheumatoid arthritis [2–4].

The neutrophil-lymphocyte ratio (NLR) is an emerging biomarker of systemic inflammation [5–8] and innate-adaptive immune system balance [6,9] that is readily accessible from a complete blood count. It has the benefit of not being influenced by physiological conditions such as dehydration and exercise [6]. NLR has been used to monitor astronaut immune function during long-duration missions [10]. Elevated NLR is also a biomarker of systemic inflammation [5,11–14], cardiovascular disease and events [6,15–18], the severity of covid-19 [19–22], mood disorders [23], cognitive impairment [24], cancer [6,7,25], dry eye [26], periodontitis [27], rheumatoid arthritis [28], cancer [12,25,29], diabetic kidney disease [30] and total mortality [6,9,14,17,31,32].

Nutrient deficiencies or inadequacies can impair immune system function and weaken the immune response [3,33–36]. The proportion of EPA and DHA in immune cell membranes can modulate inflammation via the synthesis of prostaglandins, leukotrienes, lipoxins and specialized pro-resolving lipid mediators (SPMs, e.g., resolvins, protectins, and maresins) [1,37]. The EPA and DHA-derived metabolites are less inflammatory than those derived from the omega-6 precursor, arachidonic acid [1,33,37–42]. SPMs derived from EPA and DHA reduce neutrophil infiltration and production of reactive oxygen species, regulate the cytokine-chemokine axis, and temper the inflammatory response without immunosuppression [37,43– 45]. The omega-3 index (O3I) [46] is a stable biomarker of long term EPA and DHA intake [47,48]. A low O3I [49] and an elevated NLR [14,18,50] are both associated with risk of cardiovascular events and mortality (Supplemental Table 1). Hypothesizing that low blood EPA+DHA levels may partly contribute to systemic chronic inflammation, we asked if there was a relationship between the O3I and the NLR in healthy individuals without inflammation.

2. Patients and Methods

This is a cross-sectional analysis of data from blood samples submitted for testing to Health Diagnostic Laboratory, Inc (HDL, Inc., Richmond VA; now defunct) as part of routine clinical assessment between 2011-2012. Subjects were adults (≥18y) with data on O3I, NLR, body mass index (BMI), age, sex, and high-sensitivity C-reactive protein (CRP) (n=44,925). Individuals with extreme O3I values (i.e., highest and lowest 0.5%) were excluded. Because CRP > 3mg/L is indicative of inflammation arising from infection, trauma or chronic disease [51–54], individuals with CRP >3 mg/L were also excluded. Thus, the final study population consisted of 28,871 individuals (Figure 1).

Figure 1.
Figure 1.

Analytical sample flow. NLR, neutrophil-lymphocyte ratio; O3I, omega-3 index; high-sensitivity C-reactive protein; BMI, body mass index.

2.1 Laboratory Methods

Blood samples were drawn after an overnight fast and shipped with cold packs to HDL, Inc. for testing. Samples were prepared at each clinical site according to standardized instructions as previously described [55]. Absolute concentrations of blood cells (neutrophils, lymphocytes, NLR) were determined with a Beckman-Coulter DxH 800 analyzer (Brea, CA, USA) and biomarker data (CRP, O3I) were extracted without any linked patient identifiers except age, sex, and BMI. For fatty acid analysis, RBCs were separated from plasma by centrifugation and analyzed using gas chromatography as previously described [56]. The University of South Dakota Institutional Review Board reviewed and approved the use of such de-identified clinical data for research purposes (IRB-21-147).

2.2 Statistical methods

Sample characteristics were summarized using standard statistical methods (e.g., means, SDs, correlations) with t-tests and adjusted linear models used to compare characteristics of male and female participants above and below O3I values that were ultimately identified as primary cut points in the NLR-O3I curves (see below). Splines were fit using 3rd degree polynomials with knots at each decile in R (version 3.6.2; splines package). Unadjusted models used a linear model to predict NLR values by splines of O3I. Adjusted models accounted for sex, age, BMI and CRP values in the linear models accounting for potential non-linear relationships using splines. To identify significant changes in the NLR-O3I relationship, we used a “sliding O3I window” approach. The width of each window was three O3I percentage points (e.g., 4% to 7%). By moving the window up by 0.1% increments and repeatedly testing for significant differences between the mean NLR in the lower vs. the upper half of the window, we sought to discover O3I cut points where the NLR-O3I relationship appeared to flatten. These would be O3I values above which the “effect” of an increase in O3I on NLR had little impact. We began with a window midpoint of O3I =2.6%, and we used adjusted linear models in R to test for upper vs lower half differences. We identified the first window which did not have a statistically significant difference in upper and lower mean NLR values. The midpoint of this window was chosen as the O3I cut point to be used in further analysis.

Statistical interactions with O3I values above and below the subsequently identified inflection points were tested by placing the interaction term in separate models predicting O3I, NLR, age, sex, BMI, and CRP. Pearson correlations were used to assess strength and direction of linear association between covariates and NLR. Statistical significance was set to 0.05 for all analyses and 95% confidence bands are provided where appropriate.

3. Results

The final dataset consisted of 28,871 healthy adults (Figure 1). The average age was 55.1±15.1 years, the average BMI was 27.6±5.4 kg/m2, and there were slightly more females (51%) than males. Females were significantly younger and had slightly but significantly higher O3I and CRP levels and lower NLR, neutrophil count, and BMI than males (Table 1). When the model was also adjusted for age, BMI and CRP, small but significant sex differences remained with the exception of BMI (Table 1).

View this table:
Table 1.

Characteristics of the study population. Mean±SD

NLR was significantly (p<0.0001) and inversely associated with O3I (Figure 2A). Pearson correlations (r) of other variables with NLR were r=0.06 (CRP), r=0.14 (age), r=0.01 (BMI), r=0.65 (neutrophil count), and r=-0.24 (lymphocyte count). Adjustment for age, sex, BMI, and CRP strengthened the relationship (Figure 2B). The O3I value where the relationship between O3I and NLR began to flatten (i.e., the cut point determined by the sliding window analysis described in Methods) was 6.6% although NLR continued to decline until O3I >8.5% (Figure 2B). Below 6.6%, the curve was clearly steeper than it was above 6.6%. The O3I cut point of 6.6% was explored in more detail. An O3I <6.6% was associated with significantly higher NLR, neutrophil number, lymphocyte number, CRP, BMI, and lower age (versus O3I ≥6.6%) (Table 2). These O3I-related differences persisted, except for lymphocyte number, when the model was adjusted for age, sex, BMI and CRP (Table 2).

View this table:
Table 2.

Stratification by omega-3 index (O3I) classification (n=28,871). Mean±SD

Figure 2.
Figure 2.

The unadjusted (A) and adjusted for sex, age, BMI, and CRP (B) relationship between the neutrophil-lymphocyte ration (NLR) and the omega-3 index (O3I) in 28,871 healthy adults. (Means and 95% confidence bands).

When adults with inflammation (CRP >3mg/L) were included (n=43,851), NLR was significantly and inversely related with O3I before (p<0.0001) and after adjusting for age, sex, BMI and CRP (p<0.0001) (Supplemental Figure 1). As noted above, we chose to restrict our analysis to a healthy population (i.e., without evident inflammation) to establish EPA+DHA standards that could be used to develop DRIs.

4. Discussion and Conclusions

We report a significant inverse relationship between O3I and NLR. By excluding individuals with CRP >3 mg/L, we could examine the O3I-NLR relationship in individuals without any evidence of tissue injury, infection, or systemic acute inflammation [57,58], i.e. a cohort suitable for deriving O3I standards on which Dietary Reference Intakes (DRIs) could be developed for planning and assessing EPA+DHA intakes of healthy people. NLR values measured in this cohort (Table 1) were similar to those measured in healthy adults globally [8,24,59–63]. NLR is known to increase with age [9,32,60], obesity [13,60], CRP [64,65], and to sometimes differ by sex [32,59]. These same relationships were mostly observed here as well (data not reported), suggesting that the findings from this clinical laboratory cohort are generally representative.

Inflammation is a normal physiological response to infection and injury, but unrestrained inflammation can cause tissue damage leading to disease. As noted earlier, EPA and DHA serve as precursors for the synthesis of prostaglandins, leukotrienes, lipoxins and SPMs that can mediate immune responses [1,29,33,37,39–41]. SPMs derived from EPA and DHA protect tissues by limiting acute inflammatory responses and helping achieve homeostasis without immunosuppression [37,44,45]. In a randomized, double-blind, crossover trial, supplementation (10wk) with high doses of EPA or DHA (∼8g/d) in individuals with abdominal obesity and low-grade inflammation (baseline CRP 3.3±2.4 mg/L) separated by a 9-wk washout significantly increased blood EPA and DHA concentrations (vs corn oil control) [66]. DHA, but not EPA, supplementation decreased CRP concentrations (vs control) and the authors concluded EPA and DHA had more consistent effects on anti-inflammatory gene expression than pro-inflammatory gene expression [66]. Using pairwise and network meta-analyses of randomized controlled trials, DHA and EPA seem to have similar effects on CRP, IL-6, TNF-α, and adiponectin [67]. Although EPA and DHA trigger anti-inflammatory responses in vitro [68,69], the effects of long-chain omega-3 fatty acids on plasma CRP concentrations are mixed [70–73]. A threshold blood EPA+DHA concentration may be required to fuel sufficient SPM biosynthesis to achieve meaningful resolution of inflammation [37].

Omega-3 supplementation increases the EPA+DHA content of neutrophil membranes in vivo and inhibits the 5-lipoxygenase pathway and leukotriene B4-mediated functions of neutrophils in vitro [38]. Omega-3 supplementation significantly increased plasma EPA+DHA levels (50-100%) and decreased concentrations of IL-6 (10-12% vs 36% increase in placebo group) and TNFα (0.2 to −2.3% vs 12% increase in placebo group) in healthy, middle-aged and older individuals [74]. Meta-analyses have confirmed this effect [72]. In a study of 8,237 participants living in Japan without a history of cardiovascular disease, eating fish >4 days per week was associated with significant lower NLR [75]. High omega-3 dietary intake was associated with a trend towards lower CRP (p=0.09) and NLR (p=0.17) in men with acute coronary syndrome [76]. A systematic review and meta-analysis of 18 randomized controlled trials found marine-derived omega-3 fatty acids lowered pro-inflammatory eicosanoid concentrations, e.g., in neutrophil leukotriene B4 [77]. In the long-term, chronically lower levels of inflammation may have health benefits. For example, a pooled analysis of data from 17 prospective cohort studies involving 15,720 deaths among 43,466 individuals over a median of 16 years of follow-up found blood EPA+DHA levels were inversely associated with risk for death from all causes, CVD, cancer and other causes [49].

Despite the strength of the NLR-O3I relationship, the most obvious limitation of this study is that confounding metabolic events, dietary behaviors, smoking habits and/or physical activity levels associated with O3I may also affect innate-adaptive immune system balance. However, a nationally representative study of 9,427 individuals living in the US did not find significant differences in NLR with respect to sex, education, insurance status, or drinking habits [59]. Moreover, this cross-sectional population is similar to 2/3 of the US population who have CRP <3mg/L [78] and the ∼95% of adults living in the USA with circulating O3I percentages below 5% [79,80].

In this cross-sectional study of healthy individuals, 81% of participants had O3I <6.6%. Below this threshold, an increase in NLR, reflecting an increasingly imbalanced innate-adaptive immune system, was observed. NLR continued to decrease with increasing O3I until O3I >8.5%, similar to the target proposed for cardiovascular health, i.e. O3I >8% [46,81]. Clearly additional evidence, including intervention studies, is needed to determine whether the NLR-O3I relationship is causal or coincidental.

In conclusion, red blood cell EPA+DHA levels are significantly and inversely associated with NLR, a biomarker of inflammation and innate-adaptive immune system balance. Based on our observations in this healthy cohort, an O3I >6.6%, and possibly as high as 8.5%, is associated with lower NLR values that are indicative of a quiescent, balanced innate-adaptive immune system.

Data Availability

Pending application and approval, data described in the manuscript, code book, and analytic code will be made available upon request to the Fatty Acid Research Institute.

https://www.faresinst.org/

CReditT authorship contribution statement

M.I. McBurney: Conceptualization & analytical design. Writing -original draft, review & editing. W.S. Harris: Conceptualization & analytical design. Funding acquisition. Writing- review & editing. N.L. Tintle: Formal analysis. Writing-review & editing.

Disclosures

M.I. McBurney serves on the Board of Directors of the American Society for Nutrition and has or has held consulting agreements in the past 3 years with Council for Responsible Nutrition; Church & Dwight; DSM Nutritional Products; International Life Sciences Institute, North America; McCormick; OmegaQuant Analytics; PepsiCo; and VitaMe Technologies. W.S. Harris holds an interest in OmegaQuant Analytics, a lab that offers omega-3 blood testing; and is a member of the RB Schiff Science and Innovation Advisory Board. N.L. Tintle has no conflicts to disclose.

Acknowledgements

The authors wish to thank Steven Varvel, PhD for his help in acquiring and collating the dataset used in this study.

Footnotes

  • Authors last names: McBurney, Tintle, Harris

  • Reprint requests: W.S. Harris, Fatty Acid Research Institute, Sioux Falls, SD 57106, USA. E-mail: wsh{at}faresinst.com

  • Sources of Support: This work was supported by the Fatty Acid Research Institute (FARI). FARI is a non-profit foundation bringing together nutrition scientists and biostatistical experts to accelerate discovery of the relationships between fatty acids, especially omega-3 fatty acids, and health. Pending application and approval, data described in the manuscript, code book, and analytic code will be made available upon request to the Fatty Acid Research Institute (https://www.faresinst.org/).

  • This manuscript has been revised to address the questions posed by the reviewers.

Abbreviations

BMI
body mass index
CRP
high-sensitivity C-reactive protein
DHA
docosahexaenoic acid
EPA
eicosapentaenoic acid
NLR
neutrophil-lymphocyte ratio
O3I
omega-3 index
SPM
specialized pro-resolving lipid mediators.

References

  1. [1].↵
    C.N. Serhan, Pro-resolving lipid mediators are leads for resolution physiology, Nature. 510 (2014) 92–101. https://doi.org/10.1038/nature13479.
    OpenUrlCrossRefPubMedWeb of Science
  2. [2].↵
    P.C. Calder, Marine omega-3 fatty acids and inflammatory processes: Effects, mechanisms and clinical relevance, Bioch. Biophys. Acta: Mol Cell Biol Lipids. 1851 (2015) 469–484. https://doi.org/10.1016/j.bbalip.2014.08.010.
    OpenUrl
  3. [3].↵
    Childs, Calder, Miles, Diet and Immune Function, Nutrients. 11 (2019) 1933. https://doi.org/10.3390/nu11081933.
    OpenUrl
  4. [4].↵
    D. Furman, J. Campisi, E. Verdin, P. Carrera-Bastos, S. Targ, C. Franceschi, L. Ferrucci, D.W. Gilroy, A. Fasano, G.W. Miller, A.H. Miller, A. Mantovani, C.M. Weyand, N. Barzilai, J.J. Goronzy, T.A. Rando, R.B. Effros, A. Lucia, N. Kleinstreuer, G.M. Slavich, Chronic inflammation in the etiology of disease across the life span, Nat Med. 25 (2019) 1822–1832. https://doi.org/10.1038/s41591-019-0675-0.
    OpenUrlCrossRefPubMed
  5. [5].↵
    F. Imtiaz, K. Shafique, S.S. Mirza, Z. Ayoob, P. Vart, S. Rao, Neutrophil lymphocyte ratio as a measure of systemic inflammation in prevalent chronic diseases in Asian population, International Archives of Medicine. 5 (2012) 2. https://doi.org/10.1186/1755-7682-5-2.
    OpenUrl
  6. [6].↵
    T. Bhat, S. Teli, J. Rijal, H. Bhat, M. Raza, G. Khoueiry, M. Meghani, M. Akhtar, Neutrophil to lymphocyte ratio and cardiovascular diseases: a review, Expert Rev. Cardiovasc. Ther. (2013) 6.
  7. [7].↵
    S. Socorro Faria, P.C. Fernandes Jr., M.J. Barbosa Silva, V.C. Lima, W. Fontes, R. Freitas-Junior, A.K. Eterovic, P. Forget, The neutrophil-to-lymphocyte ratio: a narrative review, Ecancer. 10 (2016). https://doi.org/10.3332/ecancer.2016.702.
  8. [8].↵
    J. Fest, R. Ruiter, M.A. Ikram, T. Voortman, C.H.J. van Eijck, B.H. Stricker, Reference values for white blood-cell-based inflammatory markers in the Rotterdam Study: a population-based prospective cohort study, Sci Rep. 8 (2018) 10566. https://doi.org/10.1038/s41598-018-28646-w.
    OpenUrl
  9. [9].↵
    M. Song, B.I. Graubard, C.S. Rabkin, E.A. Engels, Neutrophil-to-lymphocyte ratio and mortality in the United States general population, Nature Res. 11 (2021) 464. https://doi.org/10.1038/s41598-020-79431-7.
    OpenUrl
  10. [10].↵
    A.M. Paul, S.D. Mhatre, E. Cekanaviciute, A.-S. Schreurs, C.G.T. Tahimic, R.K. Globus, S. Anand, B.E. Crucian, S. Bhattacharya, Neutrophil-to-Lymphocyte Ratio: A Biomarker to Monitor the Immune Status of Astronauts, Front. Immunol. 11 (2020) 564950. https://doi.org/10.3389/fimmu.2020.564950.
    OpenUrl
  11. [11].↵
    R. Zahorec, Ratio of neutrophil to lymphocyte counts - rapid and simple parameter of systemic inflammation and stress in critically ill, Bratisl. Lek. Listy. 102 (2001) 5–14.
    OpenUrlPubMed
  12. [12].↵
    L. Venkatraghavan, T.P. Tan, J. Mehta, A. Arekapudi, A. Govindarajulu, E. Siu, Neutrophil Lymphocyte Ratio as a predictor of systemic inflammation - A cross-sectional study in a pre-admission setting., F1000Res. 4 (2015) 123. https://doi.org/10.12688/f1000research.6474.1.
    OpenUrl
  13. [13].↵
    E. Rodríguez-Rodríguez, A.M. López-Sobaler, R.M. Ortega, M.L. Delgado-Losada, A.M. López-Parra, A. Aparicio, Association between Neutrophil-to-Lymphocyte Ratio with Abdominal Obesity and Healthy Eating Index in a Representative Older Spanish Population, Nutrients. 12 (2020) 855. https://doi.org/10.3390/nu12030855.
    OpenUrl
  14. [14].↵
    H. Wada, T. Dohi, K. Miyauchi, R. Nishio, M. Takeuchi, N. Takahashi, H. Endo, M. Ogita, H. Iwata, T. Kasai, S. Okazaki, K. Isoda, S. Suwa, H. Daida, Neutrophil to Lymphocyte Ratio and Long-Term Cardiovascular Outcomes in Coronary Artery Disease Patients with Low High-Sensitivity C-Reactive Protein Level, Int. Heart J. 61 (2020) 447–453. https://doi.org/10.1536/ihj.19-543.
    OpenUrl
  15. [15].↵
    B. Suh, D.W. Shin, H.-M. Kwon, J.M. Yun, H.-K. Yang, E. Ahn, H. Lee, J.H. Park, B. Cho, Elevated neutrophil to lymphocyte ratio and ischemic stroke risk in generally healthy adults, PLoS ONE. 12 (2017) e0183706. https://doi.org/10.1371/journal.pone.0183706.
    OpenUrl
  16. [16].
    T. Angkananard, T. Anothaisintawee, M. McEvoy, J. Attia, A. Thakkinstian, Neutrophil Lymphocyte Ratio and Cardiovascular Disease Risk: A Systematic Review and Meta-Analysis, BioMed Research International. 2018 (2018) 1–11. https://doi.org/10.1155/2018/2703518.
    OpenUrl
  17. [17].↵
    N.H. Adamstein, J.G. MacFadyen, L.M. Rose, R.J. Glynn, A.K. Dey, P. Libby, I.A. Tabas, N.N. Mehta, P.M. Ridker, The neutrophil–lymphocyte ratio and incident atherosclerotic events: analyses from five contemporary randomized trials, European Heart Journal. 42 (2021) 896–903. https://doi.org/10.1093/eurheartj/ehaa1034.
    OpenUrl
  18. [18].↵
    L. Zhan, Y. Liu, Y. Cheng, W. Guo, J. Yang, Predictive Value of Neutrophil/Lymphocyte Ratio (NLR) on Cardiovascular Events in Patients with COVID-19, IJGM. Volume 14 (2021) 3899–3907. https://doi.org/10.2147/IJGM.S317380.
    OpenUrl
  19. [19].↵
    S. Qun, Y. Wang, J. Chen, X. Huang, H. Guo, Z. Lu, J. Wang, C. Zheng, Y. Ma, Y. Zhu, D. Xia, Y. Wang, H. He, Y. Wang, M. Fei, Y. Yin, M. Zheng, Y. Xu, W. Ge, F. Hu, J. Zhou, Neutrophil-to-Lymphocyte Ratios Are Closely Associated With the Severity and Course of Non-mild COVID-19, Front. Immunol. 11 (2020) 2160. https://doi.org/10.3389/fimmu.2020.02160.
    OpenUrlCrossRef
  20. [20].
    S. Sun, X. Cai, H. Wang, G. He, Y. Lin, B. Lu, C. Chen, Y. Pan, X. Hu, Abnormalities of peripheral blood system in patients with COVID-19 in Wenzhou, China, Clinica Chimica Acta. 507 (2020) 174–180. https://doi.org/10.1016/j.cca.2020.04.024.
    OpenUrl
  21. [21].
    M. Seyit, E. Avci, R. Nar, H. Senol, A. Yilmaz, M. Ozen, A. Oskay, H. Aybek, Neutrophil to lymphocyte ratio, lymphocyte to monocyte ratio and platelet to lymphocyte ratio to predict the severity of COVID-19, The American Journal of Emergency Medicine. 40 (2021) 110–114. https://doi.org/10.1016/j.ajem.2020.11.058.
    OpenUrl
  22. [22].↵
    E. Vafadar Moradi, A. Teimouri, R. Rezaee, N. Morovatdar, M. Foroughian, P. Layegh, B. Rezvani Kakhki, S.R. Ahmadi Koupaei, V. Ghorani, Increased age, neutrophil-to-lymphocyte ratio (NLR) and white blood cells count are associated with higher COVID-19 mortality, The American Journal of Emergency Medicine. 40 (2021) 11–14. https://doi.org/10.1016/j.ajem.2020.12.003.
    OpenUrlCrossRefPubMed
  23. [23].↵
    M.G. Mazza, S. Lucchi, A.G.M. Tringali, A. Rossetti, E.R. Botti, M. Clerici, Neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in mood disorders: A meta-analysis, Progress in Neuro-Psychopharmacology and Biological Psychiatry. 84 (2018) 229–236. https://doi.org/10.1016/j.pnpbp.2018.03.012.
    OpenUrlPubMed
  24. [24].↵
    J.-H. Liu, Y.-J. Zhang, Q.-H. Ma, H.-P. Sun, Y. Xu, C.-W. Pan, Elevated blood neutrophil to lymphocyte ratio in older adults with cognitive impairment, Archives of Gerontology and Geriatrics. 88 (2020) 104041. https://doi.org/10.1016/j.archger.2020.104041.
    OpenUrl
  25. [25].↵
    A.J. Templeton, M.G. McNamara, B. Šeruga, F.E. Vera-Badillo, P. Aneja, A. Ocaña, R. Leibowitz-Amit, G. Sonpavde, J.J. Knox, B. Tran, I.F. Tannock, E. Amir, Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis, JNCI: Journal of the National Cancer Institute. 106 (2014). https://doi.org/10.1093/jnci/dju124.
  26. [26].↵
    Y.-F. Meng, Q. Pu, Q. Ma, W. Zhu, X.-Y. Li, Neutrophil/lymphocyte ratio as an inflammatory predictor of dry eye: A case-control study, Therapeutics and Clinical Risk Management. 17 (2021) 259–266.
    OpenUrl
  27. [27].↵
    R. Lu, W. Li, X. Wang, D. Shi, H. Meng, Elevated neutrophil-to-lymphocyte ratio but not platelet-to-lymphocyte ratio is associated with generalized aggressive periodontitis in a Chinese population, J Periodontol. 92 (2021) 507–513. https://doi.org/10.1002/JPER.20-0282.
    OpenUrl
  28. [28].↵
    Z. Jin, G. Cai, P. Zhang, X. Li, S. Yao, L. Zhuang, M. Ren, Q. Wang, X. Yu, The value of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as complementary diagnostic tools in the diagnosis of rheumatoid arthritis: A multicenter retrospective study, J Clin Lab Anal. 35 (2021). https://doi.org/10.1002/jcla.23569.
  29. [29].↵
    L. Xia, W. Li, J. Zhai, C. Yan, J. Chen, H. Yang, Significance of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, lymphocyte-to-monocyte ratio and prognostic nutritional index for predicting clinical outcomes in T1–2 rectal cancer, BMC Cancer. 20 (2020) 208. https://doi.org/10.1186/s12885-020-6698-6.
    OpenUrl
  30. [30].↵
    L. Winter, L.A. Wong, G. Jerums, J. Seah, M. Clarke, S.M. Tan, M.T. Coughlan, R.J. MacIsaac, E.I. Ekinci, Use of Readily Accessible Inflammatory Markers to Predict Diabetic Kidney Disease, Front. Endocrinol. 9 (2018) 225. https://doi.org/10.3389/fendo.2018.00225.
    OpenUrl
  31. [31].↵
    S. Balta, S. Demirkol, M. Unlu, Z. Arslan, T. Celik, Neutrophil to lymphocyte ratio may be predict of mortality in all conditions, Br J Cancer. 109 (2013) 3125–3126. https://doi.org/10.1038/bjc.2013.598.
    OpenUrlCrossRefPubMedWeb of Science
  32. [32].↵
    J. Fest, T.R. Ruiter, B. Groot Koerkamp, D. Rizopoulos, M.A. Ikram, C.H.J. van Eijck, B.H. Stricker, The neutrophil-to-lymphocyte ratio is associated with mortality in the general population: The Rotterdam Study, Eur J Epidemiol. 34 (2019) 463–470. https://doi.org/10.1007/s10654-018-0472-y.
    OpenUrlPubMed
  33. [33].↵
    D. Wu, E.D. Lewis, M. Pae, S.N. Meydani, Nutritional Modulation of Immune Function: Analysis of Evidence, Mechanisms, and Clinical Relevance, Front. Immunol. 9 (2019) 3160. https://doi.org/10.3389/fimmu.2018.03160.
    OpenUrl
  34. [34].
    P.C. Calder, A.C. Carr, A.F. Gombart, M. Eggersdorfer, Optimal Nutritional Status for a Well-Functioning Immune System Is an Important Factor to Protect against Viral Infections, Nutrients. 12 (2020) 1181. https://doi.org/10.3390/nu12041181.
    OpenUrlCrossRef
  35. [35].
    A.F. Gombart, A. Pierre, S. Maggini, A Review of Micronutrients and the Immune System–Working in Harmony to Reduce the Risk of Infection, Nutrients. 12 (2020) 236. https://doi.org/10.3390/nu12010236.
    OpenUrlCrossRef
  36. [36].↵
    C.A. Reider, R.-Y. Chung, P.P. Devarshi, R.W. Grant, S. Hazels Mitmesser, Inadequacy of Immune Health Nutrients: Intakes in US Adults, the 2005–2016 NHANES, Nutrients. 12 (2020) 1735. https://doi.org/10.3390/nu12061735.
    OpenUrl
  37. [37].↵
    P.C. Calder, Eicosapentaenoic and docosahexaenoic acid derived specialised pro-resolving mediators: Concentrations in humans and the effects of age, sex, disease and increased omega-3 fatty acid intake, Biochimie. 178 (2020) 105–123. https://doi.org/10.1016/j.biochi.2020.08.015.
    OpenUrlCrossRefPubMed
  38. [38].↵
    T.H. Lee, R.L. Hoover, J.D. Williams, R.I. Sperling, J. Ravalese III., B.W. Spur, D.R. Robinson, E.J. Corey, R.A. Lewis, K.F. Austen, Effect of dietary enrichment with eicosapentaenoic acid and docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function, New England Journal of Medicine. 312 (1985) 217–224.
    OpenUrlCrossRefPubMedWeb of Science
  39. [39].↵
    P. Yaqoob, P.C. Calder, Fatty acids and immune function: new insights into mechanisms, Br J Nutr. 98 (2007) S41–S45. https://doi.org/10.1017/S0007114507832995.
    OpenUrlPubMedWeb of Science
  40. [40].
    E.A. Dennis, P.C. Norris, Eicosanoid storm in infection and inflammation, Nat Rev Immunol. 15 (2015) 511–523. https://doi.org/10.1038/nri3859.
    OpenUrlCrossRefPubMed
  41. [41].↵
    U. Radzikowska, A.O. Rinaldi, Z. Çelebi Sözener, D. Karaguzel, M. Wojcik, K. Cypryk, M. Akdis, C.A. Akdis, M. Sokolowska, The Influence of Dietary Fatty Acids on Immune Responses, Nutrients. 11 (2019) 2990. https://doi.org/10.3390/nu11122990.
    OpenUrl
  42. [42].↵
    J. McDaniel, Regulation of Neutrophil Function by Marine n-3 Fatty Acids—A Mini Review, Cell Biochem Biophys. (2021). https://doi.org/10.1007/s12013-021-01001-z.
  43. [43].↵
    C.N. Serhan, N. Chiang, T.E. Van Dyke, Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators, Nat Rev Immunol. 8 (2008) 349–361. https://doi.org/10.1038/nri2294.
    OpenUrlCrossRefPubMedWeb of Science
  44. [44].↵
    J. Dalli, J.W. Winkler, R.A. Colas, H. Arnardottir, C.-Y.C. Cheng, N. Chiang, N.A. Petasis, C.N. Serhan, Resolvin D3 and Aspirin-Triggered Resolvin D3 Are Potent Immunoresolvents, Chemistry & Biology. 20 (2013) 188–201. https://doi.org/10.1016/j.chembiol.2012.11.010.
    OpenUrlCrossRefPubMed
  45. [45].↵
    J.K. Colby, R.-E.E. Abdulnour, H.P. Sham, J. Dalli, R.A. Colas, J.W. Winkler, J. Hellmann, B. Wong, Y. Cui, S. El-Chemaly, N.A. Petasis, M. Spite, C.N. Serhan, B.D. Levy, Resolvin D3 and Aspirin-Triggered Resolvin D3 Are Protective for Injured Epithelia, The American Journal of Pathology. 186 (2016) 1801–1813. https://doi.org/10.1016/j.ajpath.2016.03.011.
    OpenUrlPubMed
  46. [46].↵
    W.S. Harris, C. von Schacky, The Omega-3 Index: a new risk factor for death from coronary heart disease?, Prev. Med. 39 (2004) 212–220. https://doi.org/10.1016/j.ypmed.2004.02.030.
    OpenUrlCrossRefPubMedWeb of Science
  47. [47].↵
    M.R. Flock, A.C. Skulas-Ray, W.S. Harris, T.D. Etherton, J.A. Fleming, P.M. Kris-Etherton, Determinants of erythrocyte omega-3 fatty acid content in response to fish oil supplementation: A dose–response randomized controlled trial, J. Am. Heart Assoc. 2 (2013) e000513. https://doi.org/10.1161/JAHA.113.000513.
    OpenUrlAbstract/FREE Full Text
  48. [48].↵
    R.E. Walker, K.H. Jackson, N.L. Tintle, G.C. Shearer, A. Bernasconi, S. Masson, R. Latini, B. Heydari, R.Y. Kwong, M. Flock, P.M. Kris-Etherton, A. Hedengran, R.M. Carney, A. Skulas-Ray, S.S. Gidding, A. Dewell, C.D. Gardner, S.M. Grenon, B. Sarter, J.W. Newman, T.L. Pedersen, M.K. Larson, W.S. Harris, Predicting the effects of supplemental EPA and DHA on the omega-3 index, Am. J. Clin. Nutr. 110 (2019) 1034–1040. https://doi.org/10.1093/ajcn/nqz161.
    OpenUrl
  49. [49].↵
    W.S. Harris, N.L. Tintle, F. Imamura, F. Qian, A.V. Ardisson Korat, M. Marklund, L. Djoussé, J.K. Bassett, P.-H. Carmichael, Y.-Y. Chen, Y. Hirakawa, L.K. Kupers, M. Lankinen, R.A. Murphy, C. Samieri, M.K. Senn, P. Shi, J.K. Virtanen, I.A. Brouwer, K.-L. Chien, G. Eiriksdottir, N.G. Forouhi, J.M. Geleijnse, G.G. Giles, V. Gudnason, C. Helmer, A. Hodge, R. Jackson, K.-T. Khaw, M. Laakso, H. Lai, D. Laurin, J. Lindsay, R. Micha, J. Mursu, T. Ninomiya, W. Post, B.M. Psaty, U. Riserus, J.G. Robinson, A.H. Shadyab, L. Snetselaar, A. Sala-Vila, Y. Sun, L.M. Steffen, M.Y. Tsai, N.J. Wareham, A.C. Wood, J.H.Y. Wu, F. Hu, Q. Sun, D.S. Siscovick, R.N. Lemaitre, D. Mozaffarian, F. The Fatty Acids and Outcomes Research Consortium, Blood n-3 fatty acid levels and total and cause-specific mortality from 17 prospective studies, Nature Commun. 12 (2021) 1–9. https://doi.org/10.1038/s41467-021-22370-2.
    OpenUrl
  50. [50].↵
    S. Kim, M. Eliot, D.C. Koestler, W.-C. Wu, K.T. Kelsey, Association of Neutrophil-to-Lymphocyte Ratio With Mortality and Cardiovascular Disease in the Jackson Heart Study and Modification by the Duffy Antigen Variant, (2018) 8.
  51. [51].↵
    M.A. Zimmerman, Diagnostic Implications of C-Reactive Protein, Arch Surg. 138 (2003) 220. https://doi.org/10.1001/archsurg.138.2.220.
    OpenUrlPubMed
  52. [52].
    A. Villaseñor, S.W. Flatt, C. Marinac, L. Natarajan, J.P. Pierce, R.E. Patterson, Postdiagnosis C-Reactive Protein and Breast Cancer Survivorship: Findings from the WHEL Study, Cancer Epidemiol Biomarkers Prev. 23 (2014) 189–199. https://doi.org/10.1158/1055-9965.EPI-13-0852.
    OpenUrlAbstract/FREE Full Text
  53. [53].
    M.L. Knight, The Application of High-Sensitivity C-Reactive Protein in Clinical Practice: A 2015 Update, US Pharmacist. 40 (2015) 50–53.
    OpenUrl
  54. [54].↵
    S. Jafarnejad, V. Boccardi, B. Hosseini, M. Taghizadeh, Z. Hamedifard, A Meta-analysis of Randomized Control Trials: The Impact of Vitamin C Supplementation on Serum CRP and Serum hs-CRP Concentrations, (2018). https://doi.org/10.2174/1381612824666181017101810.
  55. [55].↵
    T.D. Dayspring, S.A. Varvel, L. Ghaedi, D.L. Thiselton, J. Bruton, J.P. McConnell, Biomarkers of cholesterol homeostasis in a clinical laboratory database sample comprising 667,718 patients, Journal of Clinical Lipidology. 9 (2015) 807–816. https://doi.org/10.1016/j.jacl.2015.08.003.
    OpenUrl
  56. [56].↵
    W.S. Harris, J.V. Pottala, R.S. Vasan, M.G. Larson, S.J. Robins, Changes in erythrocyte membrane trans and marine fatty acids between 1999 and 2006 in older Americans, J. Nutr. 142 (2012) 1297–1303. https://doi.org/10.3945/jn.112.158295.
    OpenUrlAbstract/FREE Full Text
  57. [57].↵
    WHO, C-reactive protein concentrations as a marker of inflammation or infection for interpreting biomarkers of micronutrient status., World Health Organization, Geneva, Switzerland, 2014. http://apps.who.int/iris/bitstream/10665/133708/1/WHO_NMH_NHD_EPG_14.7_eng.pdf?ua=1.
  58. [58].↵
    M. Antonelli, I. Kushner, It’s time to redefine inflammation, FASEB J. 31 (2017) 1787–1791. https://doi.org/10.1096/fj.201601326R.
    OpenUrlCrossRefPubMed
  59. [59].↵
    B. Azab, M. Camacho-Rivera, E. Taioli, Average Values and Racial Differences of Neutrophil Lymphocyte Ratio among a Nationally Representative Sample of United States Subjects, PLoS ONE. 9 (2014) e112361. https://doi.org/10.1371/journal.pone.0112361.
    OpenUrlCrossRefPubMed
  60. [60].↵
    J. Li, Q. Chen, X. Luo, J. Hong, K. Pan, X. Lin, X. Liu, L. Zhou, H. Wang, Y. Xu, H. Li, C. Duan, Neutrophil-to-Lymphocyte Ratio Positively Correlates to Age in Healthy Population: NLR Correlates to Age, J. Clin. Lab. Anal. 29 (2015) 437–443. https://doi.org/10.1002/jcla.21791.
    OpenUrlCrossRef
  61. [61].
    Y. Chen, Y. Zhang, G. Zhao, C. Chen, P. Yang, S. Ye, X. Tan, Difference in Leukocyte Composition between Women before and after Menopausal Age, and Distinct Sexual Dimorphism, PLoS ONE. 11 (2016) e0162953. https://doi.org/10.1371/journal.pone.0162953.
    OpenUrlCrossRefPubMed
  62. [62].
    P. Forget, C. Khalifa, J.-P. Defour, D. Latinne, M.-C. Van Pel, M. De Kock, What is the normal value of the neutrophil-to-lymphocyte ratio?, BMC Res Notes. 10 (2017) 12. https://doi.org/10.1186/s13104-016-2335-5.
    OpenUrlCrossRefPubMed
  63. [63].↵
    J.S. Lee, N.Y. Kim, S.H. Na, Y.H. Youn, C.S. Shin, Reference values of neutrophil-lymphocyte ratio, lymphocyte-monocyte ratio, platelet-lymphocyte ratio, and mean platelet volume in healthy adults in South Korea, Medicine. 97 (2018) e11138. https://doi.org/10.1097/MD.0000000000011138.
    OpenUrlPubMed
  64. [64].↵
    C.P. de Jager, P.T. van Wijk, R.B. Mathoera, J. de Jongh-Leuvenink, T. van der Poll, P.C. Wever, Lymphocytopenia and neutrophil-lymphocyte count ratio predict bacteremia better than conventional infection markers in an emergency care unit, Crit Care. 14 (2010) R192. https://doi.org/10.1186/cc9309.
    OpenUrlCrossRefPubMed
  65. [65].↵
    J.C. Yombi, P.E. Schwab, E. Thienpont, Neutrophil-to-lymphocyte ratio (NLR) distribution shows a better kinetic pattern than C-reactive protein distribution for the follow-up of early inflammation after total knee arthroplasty, Knee Surg Sports Traumatol Arthrosc. 24 (2016) 3287–3292. https://doi.org/10.1007/s00167-015-3921-0.
    OpenUrl
  66. [66].↵
    C. Vors, J. Allaire, J. Marin, M.-C. Lépine, A. Charest, A. Tchernof, P. Couture, B. Lamarche, Inflammatory gene expression in whole blood cells after EPA vs. DHA supplementation: Results from the ComparED study, Atherosclerosis. 257 (2017) 116–122. https://doi.org/10.1016/j.atherosclerosis.2017.01.025.
    OpenUrl
  67. [67].↵
    C. Vors, J. Allaire, S.B. Mejia, T.A. Khan, J.L. Sievenpiper, B. Lamarche, Comparing the Effects of Docosahexaenoic and Eicosapentaenoic Acids on Inflammation Markers Using Pairwise and Network Meta-Analyses of Randomized Controlled Trials, Advances in Nutrition. 12 (2021) 128–140. https://doi.org/10.1093/advances/nmaa086.
    OpenUrl
  68. [68].↵
    S. Weldon, A. Mullen, C. Loscher, L. Hurley, H. Roche, Docosahexaenoic acid induces an anti-inflammatory profile in lipopolysaccharide-stimulated human THP-1 macrophages more effectively than eicosapentaenoic acid, The Journal of Nutritional Biochemistry. 18 (2007) 250–258. https://doi.org/10.1016/j.jnutbio.2006.04.003.
    OpenUrlCrossRefPubMedWeb of Science
  69. [69].↵
    R. De Caterina, J.K. Liao, P. Libby, Fatty acid modulation of endothelial activation, The American Journal of Clinical Nutrition. 71 (2000) 213S–223S. https://doi.org/10.1093/ajcn/71.1.213S.
    OpenUrlAbstract/FREE Full Text
  70. [70].↵
    E.M. Balk, A.H. Lichtenstein, M. Chung, B. Kupelnick, P. Chew, J. Lau, Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: A systematic review, Atherosclerosis. 189 (2006) 19–30. https://doi.org/10.1016/j.atherosclerosis.2006.02.012.
    OpenUrlCrossRefPubMedWeb of Science
  71. [71].
    W. Xin, W. Wei, X. Li, Effects of fish oil supplementation on inflammatory markers in chronic heart failure: a meta-analysis of randomized controlled trials, BMC Cardiovasc Disord. 12 (2012) 77. https://doi.org/10.1186/1471-2261-12-77.
    OpenUrlCrossRefPubMed
  72. [72].↵
    K. Li, T. Huang, J. Zheng, K. Wu, D. Li, Effect of Marine-Derived n-3 Polyunsaturated Fatty Acids on C-Reactive Protein, Interleukin 6 and Tumor Necrosis Factor α: A Meta-Analysis, PLoS ONE. 9 (2014) e88103. https://doi.org/10.1371/journal.pone.0088103.
    OpenUrlCrossRefPubMed
  73. [73].↵
    S. AbuMweis, S. Jew, R. Tayyem, L. Agraib, Eicosapentaenoic acid and docosahexaenoic acid containing supplements modulate risk factors for cardiovascular disease: a meta-analysis of randomised placebo-control human clinical trials, Journal of Human Nutrition and Dietetics. (2017). https://doi.org/10.1111/jhn.12493.
  74. [74].↵
    J.K. Kiecolt-Glaser, M.A. Belury, R. Andridge, W.B. Malarkey, B.S. Hwang, R. Glaser, Omega-3 supplementation lowers inflammation in healthy middle-aged and older adults: A randomized controlled trial | Elsevier Enhanced Reader, Brain, Behav. Immun. 26 (2012) 988–995. https://doi.org/10.1016/j.bbi.2012.05.011.
    OpenUrl
  75. [75].↵
    S. Tani, R. Matsuo, W. Atsumi, K. Kawauchi, T. Ashida, T. Yagi, K. Imatake, Y. Suzuki, A. Takahashi, N. Matsumoto, Y. Okumura, Higher Frequency of Fish Intake May Be Associated with a Lower Neutrophil/Lymphocyte Ratio: Anti-Atherosclerotic Effects of Fish Consumption, Ann Nutr Metab. (2021) 1–8. https://doi.org/10.1159/000515915.
  76. [76].↵
    A. Sut, K. Chizynski, M. Rózalski, J. Golanski, Dietary intake of omega fatty acids and polyphenols and its relationship with the levels of inflammatory markers in men with chronic coronary syndrome after percutaneous coronary intervention, Kardiol Pol. 78 (2020) 117–123. https://doi.org/10.33963/KP.15078.
    OpenUrl
  77. [77].↵
    J. Jiang, K. Li, F. Wang, B. Yang, Y. Fu, J. Zheng, D. Li, Effect of Marine-Derived n-3 Polyunsaturated Fatty Acids on Major Eicosanoids: A Systematic Review and Meta-Analysis from 18 Randomized Controlled Trials, PLoS One. 11 (2016). https://doi.org/10.1371/journal.pone.0147351.
  78. [78].↵
    I. Kushner, D. Rzewnicki, D. Samols, What Does Minor Elevation of C-Reactive Protein Signify?, The American Journal of Medicine. 119 (2006) 166.e17-166.e28. https://doi.org/10.1016/j.amjmed.2005.06.057.
    OpenUrl
  79. [79].↵
    R. Murphy, E. Yu, E. Ciappio, S. Mehta, M. McBurney, Suboptimal Plasma Long Chain n-3 Concentrations are Common among Adults in the United States, NHANES 2003–2004, Nutrients. 7 (2015) 10282–10289. https://doi.org/10.3390/nu7125534.
    OpenUrlPubMed
  80. [80].↵
    R.A. Murphy, P.P. Devarshi, S. Ekimura, K. Marshall, S. Hazels Mitmesser, Long-chain omega-3 fatty acid serum concentrations across life stages in the USA: an analysis of NHANES 2011–2012, BMJ Open. 11 (2021) e043301. https://doi.org/10.1136/bmjopen-2020-043301.
    OpenUrlAbstract/FREE Full Text
  81. [81].↵
    W.S. Harris, The Omega-3 Index: Clinical Utility for Therapeutic Intervention, Curr Cardiol Rep. 12 (2010) 503–508. https://doi.org/10.1007/s11886-010-0141-6.
    OpenUrlCrossRefPubMed
Back to top
Posted December 14, 2021.
Download PDF

Supplementary Material

Data/Code
Email
The Omega-3 Index is Inversely Associated with the Neutrophil-Lymphocyte Ratio in Adults
Michael I. McBurney, Nathan L. Tintle, William S. Harris
medRxiv 2021.10.22.21264656; doi: https://doi.org/10.1101/2021.10.22.21264656
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area